Tag: solution

AI-driven rapid profit impact analysis supports optimal decision-making KAWASAKI, Japan, July 3, 2025 /CNW/ -- Fujitsu Limited today announced the launch of a new solution...

AI-driven rapid profit impact analysis supports optimal decision-making KAWASAKI, Japan, July 3, 2025 /PRNewswire/ -- Fujitsu Limited today announced the launch of a new solution...

HONG KONG, July 4, 2025 /PRNewswire/ -- AsiaPay, a prominent provider of digital payment solutions in the Asia-Pacific region, announced today a partnership with...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

As Bitcoin returns to the $100,000 mark and global demand for clean energy and remote computing services continues to grow, Find Mining, a long-established cloud mining platform founded in 2018, announced that it has officially launched a new one-stop multi-currency AI cloud mining solution and supporting mobile applications, committed to providing global users with a smarter, low-threshold, and sustainable way to increase the value of digital assets.

As Bitcoin returns to the $100,000 mark and global demand for clean energy and remote computing services continues to grow, Find Mining, a long-established cloud mining platform founded in 2018, announced that it has officially launched a new one-stop multi-currency AI cloud mining solution and supporting mobile applications, committed to providing global users with a smarter, low-threshold, and sustainable way to increase the value of digital assets.

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription

Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription

Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RIB joins elite ranks alongside 11 of the most prominent construction management software solution providers for market-leading innovation and comprehensive CMS capabilities.

RIB joins elite ranks alongside 11 of the most prominent construction management software solution providers for market-leading innovation and comprehensive CMS capabilities.

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

PITTSBURGH, July 3, 2025 /PRNewswire/ -- "I wanted to create the ultimate all-in-one, portable solar power solution that enables you to harness the power...

NORWOOD, Mass., July 3, 2025 /PRNewswire/ -- The New England Center for Children (NECC), a globally recognized leader in autism education and research, has contracted...

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received Institutional Review Board (IRB) approval from Tel Aviv Sourasky Medical Center (TASMC) in Tel Aviv, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This approval will enable patient enrollment at TASMC, a leading clinical site in Israel, prior to commencing this first-in-human trial at the site.